A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)

Clinical trial NCT00092547 · COMPLETED

Trial details

NCT number: NCT00092547
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papillomavirus Infections

Start date: 2003-10-08
Primary completion: 2005-11-03
Enrollment: 1781

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.